CDH1 and squamous cell carcinoma: Such a functional relationship (and thus our argument to capitalize on it for therapeutic purposes) is further supported by results from squamous cell carcinoma cells that had been genetically engineered to stably express a dominant-negative E-cadherin fusion protein [29].